1-((3-(4-Bromophenyl)-1,2,4-oxadiazol-5-yl)methyl)-8-(4-fluorophenyl)pyrazolo[1,5-d][1,2,4]triazinone结构式
|
常用名 | 1-((3-(4-Bromophenyl)-1,2,4-oxadiazol-5-yl)methyl)-8-(4-fluorophenyl)pyrazolo[1,5-d][1,2,4]triazinone | 英文名 | 1-((3-(4-Bromophenyl)-1,2,4-oxadiazol-5-yl)methyl)-8-(4-fluorophenyl)pyrazolo[1,5-d][1,2,4]triazinone |
|---|---|---|---|---|
| CAS号 | 1216650-46-2 | 分子量 | 467.3 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C20H12BrFN6O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 1-((3-(4-Bromophenyl)-1,2,4-oxadiazol-5-yl)methyl)-8-(4-fluorophenyl)pyrazolo[1,5-d][1,2,4]triazinone |
|---|
| 分子式 | C20H12BrFN6O2 |
|---|---|
| 分子量 | 467.3 |
| InChIKey | SMHLVKRGWUMUEN-UHFFFAOYSA-N |
| SMILES | O=c1c2cc(-c3ccc(F)cc3)nn2cnn1Cc1nc(-c2ccc(Br)cc2)no1 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|